Divi's Laboratories Limited (DIVISLAB.NS)
INR 5734.5
(2.6%)
INR 5734.5
(2.6%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.17 Billion INR | -47.31% |
| 2022 | 26.89 Billion INR | 19.08% |
| 2021 | 22.58 Billion INR | 17.73% |
| 2020 | 19.18 Billion INR | 24.42% |
| 2019 | 15.41 Billion INR | 21.52% |
| 2018 | 12.68 Billion INR | 10.64% |
| 2017 | 11.46 Billion INR | -0.54% |
| 2016 | 11.53 Billion INR | 19.03% |
| 2015 | 9.68 Billion INR | 12.28% |
| 2014 | 8.62 Billion INR | 25.31% |
| 2013 | 6.88 Billion INR | 13.64% |
| 2012 | 6.05 Billion INR | 75.61% |
| 2011 | 3.45 Billion INR | 7.91% |
| 2010 | 3.19 Billion INR | 81.9% |
| 2009 | 1.75 Billion INR | 63.52% |
| 2008 | 1.07 Billion INR | -40.33% |
| 2007 | 1.8 Billion INR | 30.22% |
| 2006 | 1.38 Billion INR | 90.96% |
| 2005 | 724.4 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 7.15 Billion INR | 5.3% |
| 2023 FY | 14.17 Billion INR | -47.31% |
| 2023 Q4 | 3.5 Billion INR | -6.17% |
| 2023 Q3 | 3.73 Billion INR | -49.04% |
| 2023 Q2 | 7.32 Billion INR | 2.38% |
| 2022 Q3 | 7.18 Billion INR | 11.1% |
| 2022 Q1 | 6.44 Billion INR | -5.14% |
| 2022 FY | 26.89 Billion INR | 19.08% |
| 2022 Q2 | 6.46 Billion INR | 0.31% |
| 2022 Q4 | 6.79 Billion INR | -5.49% |
| 2021 Q2 | 6.44 Billion INR | 8.86% |
| 2021 Q4 | 6.79 Billion INR | 37.99% |
| 2021 Q3 | 4.92 Billion INR | -23.58% |
| 2021 Q1 | 5.91 Billion INR | 9.68% |
| 2021 FY | 22.58 Billion INR | 17.73% |
| 2020 Q3 | 4.34 Billion INR | -21.34% |
| 2020 FY | 19.18 Billion INR | 24.42% |
| 2020 Q4 | 5.39 Billion INR | 24.35% |
| 2020 Q2 | 5.51 Billion INR | 11.92% |
| 2020 Q1 | 4.93 Billion INR | 8.87% |
| 2019 Q1 | 4.07 Billion INR | 10.9% |
| 2019 Q3 | 3.71 Billion INR | -7.58% |
| 2019 Q4 | 4.52 Billion INR | 21.91% |
| 2019 FY | 15.41 Billion INR | 21.52% |
| 2019 Q2 | 4.01 Billion INR | -1.32% |
| 2018 Q2 | 3.95 Billion INR | 12.24% |
| 2018 FY | 12.68 Billion INR | 10.64% |
| 2018 Q4 | 3.67 Billion INR | 48.51% |
| 2018 Q3 | 2.47 Billion INR | -37.53% |
| 2018 Q1 | 3.52 Billion INR | 11.76% |
| 2017 FY | 11.46 Billion INR | -0.54% |
| 2017 Q4 | 3.15 Billion INR | 0.0% |
| 2016 FY | 11.53 Billion INR | 19.03% |
| 2015 FY | 9.68 Billion INR | 12.28% |
| 2014 Q3 | 2.39 Billion INR | 0.0% |
| 2014 FY | 8.62 Billion INR | 25.31% |
| 2013 FY | 6.88 Billion INR | 13.64% |
| 2013 Q3 | 1.9 Billion INR | 0.0% |
| 2012 Q3 | 1.59 Billion INR | 0.0% |
| 2012 FY | 6.05 Billion INR | 75.61% |
| 2011 FY | 3.45 Billion INR | 7.91% |
| 2010 FY | 3.19 Billion INR | 81.9% |
| 2009 FY | 1.75 Billion INR | 63.52% |
| 2008 FY | 1.07 Billion INR | -40.33% |
| 2007 FY | 1.8 Billion INR | 30.22% |
| 2006 FY | 1.38 Billion INR | 90.96% |
| 2005 FY | 724.4 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hester Biosciences Limited | 908.84 Million INR | -1459.13% |
| RPG Life Sciences Limited | 1.63 Billion INR | -766.402% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -910.131% |
| Ipca Laboratories Limited | 18.98 Billion INR | 25.372% |
| Aarti Drugs Limited | 1.16 Billion INR | -1113.726% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -360.903% |
| Albert David Limited | 1.02 Billion INR | -1280.894% |
| Alembic Limited | 872.45 Million INR | -1524.147% |
| Alkem Laboratories Limited | 32.83 Billion INR | 56.845% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 10.71% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -3010.287% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1338.075% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -207671.261% |
| Brooks Laboratories Limited | 51.18 Million INR | -27586.596% |
| Eris Lifesciences Limited | 4.94 Billion INR | -186.671% |
| FDC Limited | 3.49 Billion INR | -304.885% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -21.728% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1094.179% |
| Hikal Limited | 4.46 Billion INR | -217.443% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -567.08% |
| Ind-Swift Limited | 946.56 Million INR | -1396.989% |
| Innova Captab Limited | 931.03 Million INR | -1421.97% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -543.798% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -3131.102% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 1.965% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -3335.76% |
| Laurus Labs Limited | 11.9 Billion INR | -18.978% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1219.138% |
| Lupin Limited | 125.09 Billion INR | 88.673% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -8634.62% |
| Medico Remedies Limited | 59.67 Million INR | -23645.287% |
| Morepen Laboratories Limited | 1.98 Billion INR | -612.974% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1419.245% |
| Orchid Pharma Limited | 800.77 Million INR | -1669.545% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -373.059% |
| Sigachi Industries Limited | 579.88 Million INR | -2343.58% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -454.794% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 90.81% |
| Themis Medicare Limited | 1.12 Billion INR | -1158.663% |
| Unichem Laboratories Limited | 6.72 Billion INR | -110.679% |
| Vaishali Pharma Limited | 84.02 Million INR | -16763.226% |
| Venus Remedies Limited | 1.91 Billion INR | -639.452% |
| Wanbury Limited | 978.96 Million INR | -1347.446% |
| Windlas Biotech Limited | 1 Billion INR | -1307.835% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1298.735% |
| Sakar Healthcare Limited | 204.07 Million INR | -6843.39% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 74.541% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -472.872% |
| Mankind Pharma Limited | 29.27 Billion INR | 51.593% |
| Sequent Scientific Limited | 2.9 Billion INR | -388.316% |
| Neuland Laboratories Limited | 2.92 Billion INR | -383.66% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 4.208% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 69.821% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 88.683% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -576.683% |
| Wockhardt Limited | 8.48 Billion INR | -67.099% |
| Bal Pharma Limited | 555.62 Million INR | -2450.277% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 85.221% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -898.434% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -24210.313% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -551.644% |
| Shilpa Medicare Limited | 3.33 Billion INR | -324.992% |
| Valiant Laboratories Limited | 138.02 Million INR | -10165.959% |
| Ajanta Pharma Limited | 30.46 Billion INR | 53.484% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -99597.46% |
| Granules India Limited | 10.31 Billion INR | -37.402% |
| Medicamen Biotech Limited | 335.16 Million INR | -4127.743% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -3999.724% |
| Piramal Enterprises Limited | 63.65 Billion INR | 77.739% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 33.853% |
| NATCO Pharma Limited | 10.05 Billion INR | -40.883% |
| Suven Life Sciences Limited | 109.75 Million INR | -12811.162% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -30600.234% |
| Strides Pharma Science Limited | 9.16 Billion INR | -54.655% |
| Indoco Remedies Limited | 12.06 Billion INR | -17.484% |
| Alpa Laboratories Limited | 127.38 Million INR | -11024.195% |
| Lasa Supergenerics Limited | 291.17 Million INR | -4766.506% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -360.543% |